FDA Panel Turns Down Bone Drug in Prostate Ca
(medpagetoday.co) WASHINGTON (MedPage Today) -- An FDA panel has voted 12-1 against expanding the indication for Amgen's denosumab (Xgeva) to prevent the spread of prostate cancer to the bones in men with a high-risk form of the disease.
Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15800 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 15800]
updated 15800 (Medical - Urology), inserted 15, updated 0, at 2012-05-31 18:22:57
Articles from: Medical - Urology (medpagetoday.co)